Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?

Licinio Raffaele; Facciorusso Antonio; Castellaneta Nicola Maurizio; Di Leo Alfredo

首页> 外文期刊>The American Journal of Gastroenterology >Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?

【24h】

Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?

机译：熊去氧胆酸和苯扎贝特联合治疗原发性胆汁性肝硬化：自身免疫性肝病中类固醇时代的终结？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2015年第7期|共1页
作者
Licinio Raffaele; Facciorusso Antonio; Castellaneta Nicola Maurizio; Di Leo Alfredo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases? Response [J] . Sato Ken, Hosonuma Kenichi, Kusano Motoyasu, The American Journal of Gastroenterology . 2015,第7期

机译：熊去氧胆酸和苯扎贝特联合治疗原发性胆汁性肝硬化：自身免疫性肝病中类固醇时代的终结？响应
2. A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia [J] . Hosonuma Kenichi, Sato Ken, Yamazaki Yuichi, The American Journal of Gastroenterology . 2015,第3期

机译：熊去氧胆酸和苯扎贝特长期联合治疗原发性胆汁性肝硬化和血脂异常患者的前瞻性随机对照研究
3. Combination therapy of bezafibrate and ursodeoxycholic acid for primary biliary cirrhosis: A meta-analysis [J] . Zhang Yan, Chen Kan, Dai Weiqi, Hepatology research: the official journal of the Japan Society of Hepatology . 2015,第1期

机译：苯扎贝特和熊去氧胆酸联合治疗原发性胆汁性肝硬化的Meta分析
4. Ursodeoxycholic Acid therapy Affects the Cytokine Network and Plays An Immunomodulatory Role in Patients With Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis [C] . M. G. Neuman, P. Angulo, I. M. Malkiewicz, Falk Symposium . 2003

机译：核糖核酸酸治疗影响细胞因子网络，并对初级硬化胆管炎和原发性胆汁肝硬化患者发挥免疫调节作用
5. Predicting outcomes post liver transplantation in patients with primary biliary cirrhosis and primary sclerosing cholangitis. [D] . Zapatochny Rufo, Rebecca Jo. 2003

机译：预测原发性胆汁性肝硬化和原发性硬化性胆管炎患者肝移植后的结局。
6. Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis [O] . Yan Zhang, Jie Lu, Weiqi Dai, 2013

机译：熊去氧胆酸和皮质类固醇联合疗法治疗原发性胆汁性肝硬化伴自身免疫性肝炎的Meta分析
7. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely tonbsp;UDCA monotherapy: a meta-analysis [O] . Chuanyong Guo, Yan Zhang, Lei He, 2015

机译：对肝细胞癌患者的联合治疗原发性胆汁肝硬化患者对UDCA单药治疗不完全的影响：META分析

Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?

著录项

相似文献

相关主题

期刊订阅